OM compared with ENGN: revenue, margins and what each company keeps, and the suppliers and customers both name

OMOutset Medical, Inc.

Mkt capRevenueRevenue

ENGNenGene Therapeutics Inc.

Mkt capRevenueRevenue

Compare

OMOutset Medical, Inc.

ENGNenGene Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

2 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 7 '26±24.1%▼−5.77%×0.24

Q2 FY26±39.4%▲+25.62%×0.65

Q1 FY26±17.2%▼−21.05%×1.23

Feb 12 '26±15.0%▼−16.30%×1.09

ENGN1 of 4 reports

Reportimpliedrealized× implied

Q3 FY26—▲+5.49%—

= impliedOM realized, solidENGN realized, hatchedOne scale, both sides: full bar = 40%× = |realized| ÷ impliedSource: market data

OMOutset Medical, Inc.

3.93▼−6.21%· post 3.93

Mkt cap$75.8MRevenue$32MQ2 FY26Revenue$119MFY25

ENGNenGene Therapeutics Inc.

1.50▼−1.86%· post 1.50

ClosedOct 30 '26

Mkt cap$102.5MRevenue—Revenue—

Compare

ClosedOct 30 '26

OMOutset Medical, Inc.

ENGNenGene Therapeutics Inc.

3.93▼−6.21%post 3.93

Price

1.50▼−1.86%post 1.50

$75.8M

Mkt cap

$102.5M

Q2 FY26$32M

Revenue

—

FY25$119M

Revenue

—

OM3.93▼−6.21%vsENGN1.50▼−1.86%ClosedOct 30 '26